New antibody combo shows promise for Hard-to-Treat cancers
NCT ID NCT06819735
First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This early-stage trial tests a new drug called DT-7012, alone or with another cancer drug, in adults with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug is safe and can shrink tumors. About 125 people will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cabrini Health Limited
RECRUITINGMalvern, Victoria, 3144, Australia
-
Cancer Research SA
RECRUITINGAdelaide, South Australia, 5000, Australia
-
Honor Health Research Institute
NOT_YET_RECRUITINGScottsdale, Arizona, 85258, United States
-
Hôpitaux Universitaires de Strasbourg
RECRUITINGStrasbourg, 67200, France
-
Institut Bergonié
RECRUITINGBordeaux, 33076, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94800, France
-
Macquarie University Clinical Trial Unit
RECRUITINGNorth Ryde, New South Wales, 2109, Australia
-
One Clinical Research Pty Ltd
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Peninsula & South Eastern Haematology & Oncology Group
RECRUITINGFrankston, Victoria, 3199, Australia
Conditions
Explore the condition pages connected to this study.